Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2025-12-01 00:00:00 ET · period of report 2025-12-01 · accession 0001159036-25-000065 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-01 | 2025-12-01 | HALO | Connaughton Bernadette | Dir | S - Sale | $71.60 | -829 | 42.1K | -2% | -$59.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-01 | S | D | 829 | $71.60 | 42,123 | D | — | — |